The quantity and quality of end-of-life-care (EOLC) information in commonly used pharmacy textbooks were studied. EOLC content in each of eight best-selling pharmacy textbooks was assigned to 1 of 13 domains; there were a total of 104 possible domains for all eight books. Every mention of EOLC was given a score of 2 for "helpful content present" or 1 for "minimal content present." The quantity of EOLC content was assessed by tabulating the raw number of entries. The average number of EOLC-related entries per book ranged from 1.0 (ethics) to 27.5 (natural history). Eighty-one domains (78%) had fewer than 10 entries, 66 (63%) had 5 or fewer entries, and 28 (27%) had 1 entry or none. The overall quality of content was low, especially in the domains of spiritual issues, ethics, and context of care. The results were consistent with findings for medicine and nursing textbooks. A review of eight commonly used pharmacy textbooks revealed inadequate coverage of EOLC.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/ajhp/60.12.1246 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Organoleptic, physicochemical, phytochemical and pharmacological evaluation of six medicated ghee used for Ayurvedic management of Epilepsy.
J Ayurveda Integr Med
December 2024
Department of Pharmacognosy, Goa College of Pharmacy, Panaji, Goa University, Goa, 403 001, India.
Article Synopsis
- This study explores Ayurvedic formulations, specifically polyherbal medicated ghee (Ghrita), for managing epilepsy by testing their effects on seizure activity in mice.
- Six marketed Ghrita formulations, including Baidyanath Brahmi Ghrita (BBG), were analyzed for their physical, chemical, and pharmacological properties, using systematic testing methods.
- Results indicate that BBG provides the best protection against convulsions induced by pentylene tetrazole (PTZ), showcasing its potential as an effective treatment for epilepsy.
FAHD1 and mitochondrial metabolism: a decade of pioneering discoveries.
FEBS J
December 2024
Faculty of Biology, Institute for Biomedical Aging Research, Universität Innsbruck, Austria.
This review consolidates a decade of research on fumarylacetoacetate hydrolase domain containing protein 1 (FAHD1), a mitochondrial oxaloacetate tautomerase and decarboxylase with profound implications in cellular metabolism. Despite its critical role as a regulator in mitochondrial metabolism, FAHD1 has remained an often-overlooked enzyme in broader discussions of mitochondrial function. After more than 12 years of research, it is increasingly clear that FAHD1's contributions to cellular metabolism, oxidative stress regulation, and disease processes such as cancer and aging warrant recognition in both textbooks and comprehensive reviews.
View Article and Find Full Text PDFPopulation-Based Study of the Epidemiology of Stiff Person Syndrome in a Large Colorado-Based Health System.
Neurology
December 2024
From the Department of Neurology (P.D.C., S.S.), and Department of Biostatistics & Informatics (S.S.), University of Colorado Anschutz Medical Campus; University of Colorado School of Medicine Anschutz Medical Campus (R.D., P.W., E.E., B.V., E.M., K.V.N., A.M.C., A.L.P.); University of Colorado School of Medicine (R.F.), Aurora; School of Osteopathic Medicine (R.F.), Kanas City University, MO; University of Colorado School of Medicine Anschutz Medical Campus (R.V.C.); School of Medicine (R.V.C.), Aurora, CO; Renown Health (R.V.C.), Reno, NV; Rocky Mountain MS Center (K.V.N., A.L.P.), University of Colorado School of Medicine; and Skaggs School of Pharmacy and Pharmaceutical Sciences (K.V.N.), University of Colorado Anschutz Medical Campus, Aurora.
Article Synopsis
- Stiff person syndrome spectrum disorder (SPSD) is a rare autoimmune condition with estimated prevalence of 1-2 cases per million, marked by muscle stiffness and painful spasms; this study aims to clarify its incidence and prevalence using data from the University of Colorado Health system.
- A total of 273 patients were identified with potential SPSD diagnosis codes, but only 59 were confirmed to have the disorder, leading to a prevalence estimate of 2.11 cases per 100,000 persons.
- Different clinical diagnostic criteria were assessed, revealing varying estimated prevalence rates for SPSD, indicating inconsistencies in diagnosis and classification within the population studied.
Ethnopharmacological Perspective for Treatment of Epilepsy: An Updated Review.
Scientifica (Cairo)
November 2024
Department of Pharmacology, ICFAI School of Pharmaceutical Sciences, The ICFAI University, Jaipur, Rajasthan, India.
Plants have been used as healing agents since humanity began. This review presents the plant profiles inhabiting the world regarding their traditional usage by various tribes/ethnic groups for the treatment of epilepsy. The bibliographic investigation was carried out by analyzing standard reference textbooks, Science Direct, Google Scholar, Scopus, Medline, Web of Science, and PubMed databases.
View Article and Find Full Text PDFTrends of in vitro pharmacological potency and in vivo pharmacokinetics parameters of modern drugs: Can the therapeutic/subtherapeutic dose be estimated from in vitro K and pharmacokinetic parameters?
Clin Transl Sci
December 2024
iHuman Institute, ShanghaiTech University, Shanghai, China.
Article Synopsis
- * Modern oral drugs have improved pharmacological potency and lower daily doses compared to classic drugs, but they also show a higher intrinsic clearance rate, challenging the expectation that more potency leads to lower dosages.
- * The study highlights the importance of using a target receptor occupancy-optimized approach for estimating therapeutic doses and warns about the risk of overdosing in FIH trials, pointing out the need to consider the concentration-to-K ratio in dose estimations.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!